6533b7ddfe1ef96bd12740bf

RESEARCH PRODUCT

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

N. Oliver RamírezAndrés CervantesRamón LimónDavid NavarroSalvador PeiróEstela GiménezS. PeiroJ. Sánchez-payáDolores SalasDavid NavarroMaría Jesús AlcarazJosé Sánchez-payáD.j. BurksH. Vanaclocha LunaR. Meneu De GuillernaM. Vento TorresJ. Díez-domingoJavier Díez-domingoIñaki ComasC. Ferrer AlbiachFernando González-candelasJavier S. BurgosIldefonso Hernández-aguadoEliseo AlbertJ.s. BurgosHermelinda VanaclochaE. Zapater Latorre

subject

MaleMicrobiology (medical)medicine.medical_specialtyCOVID-19 VaccinesSARS-CoV-2-S antibodiesFingerstickSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Nursing home residentsCD8-Positive T-LymphocytesAntibodies ViralImmune systemComirnaty®COVID-19 vaccineInternal medicinemedicineHumansProspective StudiesProspective cohort studyAgedAged 80 and overVenipuncturebiologybusiness.industrySARS-CoV-2COVID-19General MedicineNursing HomesVaccinationInfectious Diseasesbiology.proteinFemaleOriginal ArticleAntibodybusinessCD8

description

6 páginas, 2 figuras, 3 tablas. Se puede acceder al texto completo de este artículo desde PubMedCentral: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490129 . Los datos de investigación utilizados en el mismo, se encuentran disponibles en: https://doi.org/10.1016/j.cmi.2021.09.031.

yearjournalcountryeditionlanguage
2022-02-01
10.1016/j.cmi.2021.09.031http://hdl.handle.net/10261/275381